JAMP TOFACITINIB

Опис товару

About JAMP TOFACITINIB

JAMP TOFACITINIB is a prescription medication containing the active ingredient tofacitinib citrate, a Janus kinase (JAK) inhibitor. It is used to treat adults with moderate to severe rheumatoid arthritis who have had an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs (DMARDs).

Key Benefits & Uses

• Treatment of moderate to severe rheumatoid arthritis in adults who have had an inadequate response or intolerance to one or more DMARDs.
• Reduction of signs and symptoms in patients with active rheumatoid arthritis.
• Improvement in physical function in patients with active rheumatoid arthritis.

Active Ingredient & Action

TOFACITINIB (TOFACITINIB CITRATE) works by blocking the activity of certain enzymes (JAKs) in the body that are involved in inflammation and immune response. By inhibiting these enzymes, tofacitinib reduces the production of pro-inflammatory cytokines and mediators, leading to a decrease in inflammation and joint damage.

Important Notes

It is essential to consult a healthcare professional before taking JAMP TOFACITINIB. The medication may increase the risk of serious infections, including tuberculosis (TB), and malignancies, such as lymphoma and non-melanoma skin cancer. Patients should be monitored regularly for signs and symptoms of infection and malignancy. Additionally, JAMP TOFACITINIB may interact with other medications, including warfarin and other anticoagulants, and may increase the risk of gastrointestinal perforation and diverticulitis.